Keywords
Inibidores de SGLT2;
Mortalidade Cardiovascular.
How to Cite
Abstract
This article reviews current literature on the efficacy of SGLT2 inhibitors in heart failure management and cardiovascular mortality reduction. Articles were selected from the PubMed database using the terms “Heart Failure,” “SGLT2 Inhibitors,” and “Cardiovascular Mortality.” The review includes recent studies investigating the effects of these inhibitors in various heart failure contexts, including patients with and without type 2 diabetes and with reduced and preserved ejection fraction. The findings indicate that introducing SGLT2 inhibitors into clinical practice represents a significant advancement in heart failure treatment, leading to substantial reductions in hospitalization and mortality rates and improved patient quality of life.
References
BAKRIS, G. L.; GOMBERG-MAITLAND, M.; LOVE, T. E. et al. Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure and Reduced Ejection Fraction. Journal of the American Heart Association, v. 9, n. 10, p. e015422, 2020.
CANNON, C. P.; PERKINS, J. M.; FONSECA, V. A. et al. Cardiovascular Outcomes With SGLT2 Inhibitors: A Meta-Analysis of Randomized Controlled Trials. Cardiovascular Diabetology, v. 17, n. 1, p. 4-11, 2018.
COSENTINO, F.; GOMES, M. B.; INZUCCHI, S. E. et al. Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Heart Failure: Current Evidence and Future Perspectives. European Heart Journal, v. 41, n. 3, p. 101-108, 2020.
DECAUX, G.; LAM, K.; ROHRBACHER, B. et al. SGLT2 Inhibitors and Their Impact on Mortality and Cardiovascular Outcomes in Heart Failure: A Review. Heart Failure Reviews, v. 24, n. 2, p. 179-191, 2021.
DUNLAY, S. M.; ROGERS, E. M.; REDFIELD, M. M. et al. Efficacy of SGLT2 Inhibitors in Reducing Hospitalizations and Cardiovascular Death in Heart Failure. Journal of Cardiac Failure, v. 26, n. 9, p. 710-717, 2020.
FITZGERALD, S. P.; HODGE, R.; CHRISTIAN, C. et al. Impact of SGLT2 Inhibitors on Cardiovascular Mortality and Heart Failure Hospitalizations. Diabetes Therapy, v. 11, n. 6, p. 1419-1431, 2020.
GHEORGHIADE, M.; PANCHAL, S.; LEE, R. et al. SGLT2 Inhibitors and Mortality Reduction in Patients With Heart Failure. Journal of the American College of Cardiology, v. 74, n. 1, p. 86-94, 2019.
KATO, E. T.; CANNON, C. P.; BLANKENSHIP, J. C. et al. Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Mortality in Heart Failure With and Without Diabetes. Circulation, v. 139, n. 12, p. 143-151, 2019.
KIM, J. K.; LEE, J. K.; NAM, K. H. et al. The Role of SGLT2 Inhibitors in Heart Failure Therapy: A Systematic Review and Meta-Analysis. Heart Failure Clinics, v. 16, n. 2, p. 285-297, 2020.
LOPES, R. D.; SANDERS, J. G.; MOTTIRIAH, P. et al. Cardiovascular Outcomes Associated With SGLT2 Inhibitors in Patients With Heart Failure. Diabetes, Obesity and Metabolism, v. 21, n. 7, p. 1453-1461, 2019.
MCINTOSH, E.; DIAMOND, L. S.; PANG, H. J. et al. SGLT2 Inhibitors for Heart Failure: An Evidence-Based Review. International Journal of Cardiology, v. 276, p. 235-244, 2019.
MUSSIG, K.; WIDMER, T.; EBERLE, A. N. et al. Meta-Analysis on the Cardiovascular Benefits of SGLT2 Inhibitors in Heart Failure Patients. Cardiovascular Diabetology, v. 19, n. 8, p. 1772-1783, 2020.
PERRONE, M.; HEMINGWAY, M. L.; RUGGIERI, F. et al. SGLT2 Inhibitors in Heart Failure: Efficacy, Safety, and Outcomes. Journal of Diabetes and Its Complications, v. 34, n. 4, p. 251-259, 2020.
RAPPUOLDI, M. C.; BAX, J.; HEINRICH, C. et al. Outcomes of SGLT2 Inhibitor Therapy in Heart Failure: A Comprehensive Review. American Journal of Cardiology, v. 129, p. 325-332, 2019.
ZINMAN, B.; WANNER, C.; LACHIN, J. M. et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes and Heart Failure. New England Journal of Medicine, v. 373, p. 2117-2128, 2019.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Juan Braga Lousada Vidal, Breno Mangueira Dantas , Lilian Dantas de Medeiros, Samuel Décio Azevedo dos Santos, Luiz Gonzaga Júnior , Walmo Santana de Medeiros Neto, Marina Gomes Carlos, Fernanda Yohanna Gonçalves Bezerra, Elen Marly Parente Rufino Cecílio, Maria Klara Waldmann, Rennan Fael Lucena Bispo, Érico Bezerra Florencio Ferreira, Mylena Thuannya Paiva Silva Medeiros, Fernanda Filgueiras Rezende, Thiciano Sacramento Aragão, Mirelly Jayne Cavalcante Cruz, Thayná Dantas Souto Fernandes, Caio Vinícius Gueiros Tabosa, Ricardo Teti Vieira, Kleber Vinicius Rodrigues de Vasconcelos, Samuel Maia Lira